In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Akoya Biosciences Inc (NASDAQ: AKYA) closed at $2.14 in the last session, down -2.73% from day before closing price of $2.20. In other words, the price has decreased by -$2.73 from its previous closing price. On the day, 0.14 million shares were traded. AKYA stock price reached its highest trading level at $2.26 during the session, while it also had its lowest trading level at $2.11.
Ratios:
We take a closer look at AKYA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 1.85 and its Current Ratio is at 2.75. In the meantime, Its Debt-to-Equity ratio is 6.23 whereas as Long-Term Debt/Eq ratio is at 5.96.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Craig Hallum on November 15, 2024, Downgraded its rating to Hold and sets its target price to $5 from $7 previously.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 11 ’24 when McKelligon Brian sold 7,500 shares for $2.08 per share. The transaction valued at 15,630 led to the insider holds 224,733 shares of the business.
McKelligon Brian sold 7,500 shares of AKYA for $15,064 on Jun 06 ’24. The President and CEO now owns 224,733 shares after completing the transaction at $2.01 per share. On Mar 20 ’24, another insider, McKelligon Brian, who serves as the President and CEO of the company, sold 7,500 shares for $4.97 each. As a result, the insider received 37,243 and left with 231,868 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AKYA now has a Market Capitalization of 106065680 and an Enterprise Value of 194407392. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.22 while its Price-to-Book (P/B) ratio in mrq is 7.77. Its current Enterprise Value per Revenue stands at 2.086 whereas that against EBITDA is -4.923.
Stock Price History:
Over the past 52 weeks, AKYA has reached a high of $6.31, while it has fallen to a 52-week low of $1.88. The 50-Day Moving Average of the stock is -23.76%, while the 200-Day Moving Average is calculated to be -32.79%.
Shares Statistics:
According to the various share statistics, AKYA traded on average about 154.45K shares per day over the past 3-months and 286970 shares per day over the past 10 days. A total of 49.12M shares are outstanding, with a floating share count of 19.98M. Insiders hold about 59.70% of the company’s shares, while institutions hold 24.54% stake in the company. Shares short for AKYA as of 1730332800 were 1601700 with a Short Ratio of 8.22, compared to 1727654400 on 2355998. Therefore, it implies a Short% of Shares Outstanding of 1601700 and a Short% of Float of 5.3400002.
